Autor: |
Elif Karaaslan, Teresa E. Sorvillo, Florine E. M. Scholte, Troy Justin O’Neal, Stephen R. Welch, Katherine A. Davies, JoAnn D. Coleman-McCray, Jessica R. Harmon, Jana M. Ritter, Scott D. Pegan, Joel M. Montgomery, Jessica R. Spengler, Christina F. Spiropoulou, Éric Bergeron |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
npj Vaccines, Vol 9, Iss 1, Pp 1-16 (2024) |
Druh dokumentu: |
article |
ISSN: |
2059-0105 |
DOI: |
10.1038/s41541-024-00931-y |
Popis: |
Abstract Immunizing mice with Crimean-Congo hemorrhagic fever virus (CCHFV) nucleoprotein (NP), glycoprotein precursor (GPC), or with the GP38 domain of GPC, can be protective when the proteins are delivered with viral vectors or as a DNA or RNA vaccine. Subunit vaccines are a safe and cost-effective alternative to some vaccine platforms, but Gc and Gn glycoprotein subunit vaccines for CCHFV fail to protect despite eliciting high levels of neutralizing antibodies. Here, we investigated humoral and cellular immune responses and the protective efficacy of recombinant NP, GP38, and GP38 forms (GP85 and GP160) associated with the highly glycosylated mucin-like (MLD) domain, as well as the NP + GP38 combination. Vaccination with GP160, GP85, or GP38 did not confer protection, and vaccination with the MLD-associated GP38 forms blunted the humoral immune responses to GP38, worsened clinical chemistry, and increased viral RNA in the blood compared to the GP38 vaccination. In contrast, NP vaccination conferred 100% protection from lethal outcome and was associated with mild clinical disease, while the NP + GP38 combination conferred even more robust protection by reducing morbidity compared to mice receiving NP alone. Thus, recombinant CCHFV NP alone is a promising vaccine candidate conferring 100% survival against heterologous challenge. Moreover, incorporation of GP38 should be considered as it further enhances subunit vaccine efficacy by reducing morbidity in surviving animals. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|